1-6 of 6
Raynell J. Clark
Close
Sort by
Journal Articles

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

Clinical Trials & Observations
Shaji Kumar, Angela Dispenzieri, Jerry A. Katzmann, Dirk R. Larson, Colin L. Colby, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Nelson Leung, Steve R. Zeldenrust, Marina Ramirez-Alvarado, Raynell J. Clark, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz
Journal: Blood
Blood (2010) 116 (24): 5126–5129.
https://doi.org/10.1182/blood-2010-06-290668
Published: 2010
Journal Articles

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Clinical Trials & Observations
Ola Landgren, Robert A. Kyle, Ruth M. Pfeiffer, Jerry A. Katzmann, Neil E. Caporaso, Richard B. Hayes, Angela Dispenzieri, Shaji Kumar, Raynell J. Clark, Dalsu Baris, Robert Hoover, S. Vincent Rajkumar
Journal: Blood
Blood (2009) 113 (22): 5412–5417.
https://doi.org/10.1182/blood-2008-12-194241
Published: 2009
Journal Articles

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Angela Dispenzieri, Robert A. Kyle, Jerry A. Katzmann, Terry M. Therneau, Dirk Larson, Joanne Benson, Raynell J. Clark, L. Joseph Melton, III, Morie A. Gertz, Shaji K. Kumar, Rafael Fonseca, Diane F. Jelinek, S. Vincent Rajkumar
Journal: Blood
Blood (2008) 111 (2): 785–789.
https://doi.org/10.1182/blood-2007-08-108357
Published: 2008
Journal Articles

Prognostic Value of the Serum Free Light Chain Ratio in Patients with Newly Diagnosed Myeloma: Proposed Incorporation into the International Staging System.

Christine L.H. Snozek, PhD, Jerry A. Katzmann, PhD, Robert A. Kyle, MD, Angela Dispenzieri, MD, Dirk R. Larson, Raynell J. Clark, Philip R. Greipp, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2007) 110 (11): 659.
https://doi.org/10.1182/blood.V110.11.659.659
Published: 2007
Journal Articles

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

Clinical Trials & Observations
S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau, L. Joseph Melton, III, Arthur R. Bradwell, Raynell J. Clark, Dirk R. Larson, Matthew F. Plevak, Angela Dispenzieri, Jerry A. Katzmann
Journal: Blood
Blood (2005) 106 (3): 812–817.
https://doi.org/10.1182/blood-2005-03-1038
Published: 2005
Journal Articles

Presence of an Abnormal Serum Free Light Ratio Is an Independent Risk Factor for Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS).

S. Vincent Rajkumar, MD, Robert A. Kyle, MD, Terry M. Therneau, PhD, L. Joseph Melton, III, MD, Arthur R. Bradwell, MB ChB, Raynell J. Clark, Dirk R. Larson, Matthew F. Plevak, Jerry A. Katzmann, PhD
Journal: Blood
Blood (2004) 104 (11): 3647.
https://doi.org/10.1182/blood.V104.11.3647.3647
Published: 2004